Market Place
Sourcing Support
Biosense Begins Enrollment of Trial Evaluating the Laminar Left Atrial Device?
27 Feb 2024 //
PRESS RELEASE
Biosense Receives FDA Approval for Multiple Atrial Fibrillation Ablation Product
04 Aug 2023 //
PRESS RELEASE
Biosense Webster Launches HELIOSTAR in Europe
13 Oct 2022 //
PRESS RELEASE
Rexahn & BioSense Enter License Agreement
16 Apr 2019 //
GLOBENEWIRE
BioSense Exercises $75M Option For China Rights To Neovacs` Lupus Immunotherapy
15 Oct 2018 //
SEEKING ALPHA
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.